Alliance Healthcare Services, Inc. (NASDAQ:AIQ) shares moved down -0.42% in last trading session and ended the day at $7.15. AIQ Gross Margin is 44.00% and its has a return on assets of 1.60%. Alliance Healthcare Services, Inc. (NASDAQ:AIQ) quarterly performance is -9.26%.
Alliance HealthCare Services, Inc. (NASDAQ:AIQ) announced that Rhonda Longmore-Grund has accepted the role of Executive Vice President and Chief Financial Officer (CFO) as part of a planned transition. Howard Aihara will step down from the CFO role once the 2015 Audit and 10K filing is complete, and will serve in an advisory capacity following that until the end of April. Aihara, who has been with the Company for 15 years, is stepping down to pursue other interests.
Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) ended the last trading day at $3.47. Company weekly volatility is calculated as 6.13% and price to cash ratio as 22.32. Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) showed a weekly performance of 6.44%.
Great Lakes Dredge & Dock Corporation (NASDAQ:GLDD) announced that it will release its financial results for the three and twelve months ended December 31, 2015 on Tuesday, February 23, 2016 at 7:00 a.m. C.S.T. A conference call with the Company will be held the same day at 9:00 a.m. C.S.T.
On 18 February, ClearOne, Inc. (NASDAQ:CLRO) shares advanced 0.41% and was closed at $12.25. CLRO EPS growth in last 5 year was 63.30%. ClearOne, Inc. (NASDAQ:CLRO) year to date (YTD) performance is -5.26%.
ClearOne (NASDAQ:CLRO), announced that it has been awarded a new patent on technology that facilitates multi-camera/multi-display video conferencing. On February 16, 2016, the U.S. Patent and Trademark Office (“USPTO”) issued United States Patent number 9,264,668 entitled “A Methodology for Negotiating Video Camera and Display Capabilities in a Multi-Camera/Multi-Display Video Conferencing Environment.” The ‘668 patent describes a method for video conferencing systems, equipped with multiple cameras and displays, to communicate with other similarly equipped systems to determine the relative spatial placement of cameras and displays.
Amgen Inc. (NASDAQ:AMGN) shares moved down -1.17% in last trading session and ended the day at $149.30. AMGN Gross Margin is 80.50% and its has a return on assets of 9.80%. Amgen Inc. (NASDAQ:AMGN) quarterly performance is -2.69%.
Amgen (NASDAQ: AMGN) announced that the randomized, double-blind, placebo-controlled Phase 3 Aranesp (darbepoetin alfa) ARCADE trial met its primary endpoint of reducing the incidence of red blood cell transfusions in anemic patients with low and intermediate-1 risk MDS at the end of the blinded 25-week study period. Aranesp also significantly improved erythroid response, a key measure of the formation of new red blood cells. Detailed results will be submitted to a future medical conference and for publication.
Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) caters to the Healthcare space. Its weekly performance is -2.71%. On the last day of trading company shares ended up at $5.74.
Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), announced that it will announce fourth quarter and fiscal year 2015 ended December 31, 2015 financial results and host a conference call and webcast on Thursday, March 3.
Leave a Reply